BioSpace News Archive

Business

CASI PHARMACEUTICALS TO REPORT FIRST QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL MAY 12, 2022

CASI Pharmaceuticals, Inc. today announced the Company will host a conference call reviewing the financial results for the first quarter of 2022, at 8:00 a.m. EST on Thursday , May 12, 2022.

May 2, 2022
·
1 min read
Biotech Beach

Ionis to host 2022 virtual Annual Meeting of Stockholders

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2022 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 2, 2022.

May 2, 2022
·
2 min read
Business

Axsome Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Axsome Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2022.

May 2, 2022
·
12 min read
Business

Enanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2022

Enanta Pharmaceuticals, Inc. today announced that it plans to report its financial results for its fiscal second quarter ended March 31, 2022 after the U.S. market closes on May 9, 2022.

May 2, 2022
·
2 min read
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

BELLUS Health Inc. today announced that three late-breaking abstracts reviewing clinical data from the Phase 2b SOOTHE trial will be presented at the upcoming American Thoracic Society (ATS) 2022 Conference.

May 2, 2022
·
2 min read
Deals

Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary

Antibe Therapeutics Inc. is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited.

May 2, 2022
·
4 min read
BioMidwest

Forge Biologics Announces 7 Presentations at the Upcoming Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Forge Biologics announced today that it will deliver seven presentations during the upcoming American Society of Gene and Cell Therapy’s (ASGCT) 25th Annual Meeting, taking place May 16-19, 2022, in Washington, D.C.

May 2, 2022
·
3 min read
Business

Junshi Biosciences and Coherus Receive Complete Response Letter from U.S. FDA for Toripalimab BLA

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) announced today that the U.S. Food and Drug Administration (“FDA”, “the Agency”) has issued a complete response letter (“CRL”) for the Biologics License Application (“BLA”).

May 2, 2022
·
11 min read
Bio NC

Atsena Therapeutics Announces Presentations at ARVO 2022 Annual Meeting and ASGCT 25th Annual Meeting

Atsena Therapeutics today announced that research on two of its next-generation adeno-associated virus (AAV) technologies will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting, which is being held May 1-4 in Denver.

May 2, 2022
·
3 min read
Lone Star Bio

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2022

Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, announced equity inducement grants to 3 new employees consisting of an aggregate of 33,000 stock options.

May 2, 2022
·
1 min read